Vitaminka reported consolidated earnings results for the first of 2019. For the period, the company reported that its consolidated net profit plunged by an annual 87% to MKD 5.7 million ($103,000/EUR 93,000). Operating revenue grew 15% to MKD 1.15 billion. Domestic sales added 17% to MKD 687 million, while sales abroad were 12% higher at MKD 439 million.